By: Denis G. Rancourt, Marine Baudin, Jérémie Mercier
We analyzed all-cause mortality by week (ACM/w) for Canada, and for the Canadian provinces, and by age group and sex, from January 2010 through March 2021; in comparison with data for other countries and their regions or counties.
We find that there is no extraordinary surge in yearly or seasonal mortality in Canada, which can be ascribed to a COVID-19 pandemic; and that several prominent features in the ACM/w in the COVID-19 period exhibit anomalous province-to-province heterogeneity that is irreconcilable with the known behaviour of epidemics of viral respiratory diseases (VRDs). We conclude that a pandemic did not occur.
In addition, our analysis of the ACM/w, by province, age and sex, allows us to highlight anomalies, occurring during the COVID-19 period, which provide strong evidence that:
• Among the most elderly (85+ years), many died from the immediate response to the pandemic that was announced by the WHO on 11 March 2020.
• Predominantly young males (0-44 years, and also 45-64 years) probably indirectly died from the sustained pandemic response, in the summer months of 2020, and into the fall and winter, starting in May 2020, especially in Alberta, significantly in Ontario and British Columbia, whereas not in Quebec.
Our study provides constraints on the mechanisms at play in VRD epidemics.
Before COVID-19, Moderna was in danger of hemorrhaging investors, as persistent safety concerns and other doubts about its mRNA delivery system threatened its entire product pipeline. Fear caused by the pandemic crisis made those concerns largely evaporate, even though there is no proof that they were ever resolved…
Not only did the COVID-19 crisis obliterate hurdles that had previously prevented Moderna from taking a single product to market, it also dramatically reversed the company’s fortunes. Indeed, from 2016 right up until the emergence of COVID-19, Moderna could barely hold it together, as it was shedding key executives, top talent, and major investors at an alarming rate. Essentially, Moderna’s promise of “revolutionizing” medicine and the remarkable salesmanship and fund-raising capabilities of the company’s top executive, were the main forces keeping it afloat. In the years leading up to the COVID-19 crisis, Moderna’s promises rang increasingly hollow, as the company’s long-standing penchant for extreme secrecy meant that—despite nearly a decade in business—it had never been able to definitively prove that it could deliver the “revolution” it had continually assured investors was right around the corner…
As this two-part series will show, safety concerns about Moderna were known well before the COVID crisis, yet they have been ignored by health authorities and the media during the crisis itself. In addition, in order to stave off collapse, Moderna must keep selling its COVID-19 vaccine for years to come. In other words, without the approval of its booster, which has caused great controversy even among the country’s top vaccine officials, Moderna faces a massive financial reckoning. While the COVID-19 crisis threw the company a lifeboat, the administration of its COVID-19 vaccine, in which the US government has now invested nearly $6 billion, must continue into the foreseeable future for the bailout to be truly successful. Otherwise, a company now worth $126.7 billion, with major investments from the US government, US military, and ties to the world’s wealthiest individuals, will crumble in short order…
Although lacking a background in mRNA and the science behind its use as a therapeutic, [Moderna’s top executive, who still heads the company] has made up for it by becoming Moderna’s salesman par excellence. Under his leadership, Moderna became “loath to publish its work in Science or Nature, but enthusiastic to herald its potential on CNBC and CNN.” In other words, under Bancel, the company came to promote its science through media publicity and public relations rather than by publishing actual data or scientific evidence. When two of its vaccine candidates entered phase 1 human trials in 2016 (trials that ultimately went nowhere), the company declined to list them on the public federal registry ClinicalTrials.gov. The decision not to list, which deviates from common practice by Moderna’s competitors and other more traditional vaccine companies, meant that the information on the safety of these vaccine candidates would likely never be publicly available after the trial’s conclusion. Moderna also refused to publicly comment on what diseases these vaccines were meant to target…
Many of the problems with Moderna that Garde identified in 2016 continued to plague the company right up until the beginning of the COVID-19 crisis. Chief among these was Moderna’s struggle to prove that its technology worked and that it was safe. Concerns about the safety and efficacy of the company’s products, which were publicly reported beginning in 2017, evaporated in the wave of panic surrounding COVID-19 and the simultaneous “Warp Speed” race for a vaccine that would “end the pandemic.” Yet, there is little, if any, evidence that these once-well-recognized concerns were addressed prior to the US government’s emergency use authorization of Moderna’s COVID-19 vaccine and its now widespread use in many countries around the world. To the contrary, there is evidence that these concerns were covered up both prior to and during the development of its vaccine…
[UPDATE: as of 11am ET on 10/6 over 10,700 doctors & scientists have signed the Rome Declaration. Please join us by reading and signing below.]
WHEREAS, it is our utmost responsibility and duty to uphold and restore the dignity, integrity, art and science of medicine;
WHEREAS, there is an unprecedented assault on our ability to care for our patients;
WHEREAS, public policy makers have chosen to force a “one size fits all” treatment strategy, resulting in needless illness and death, rather than upholding fundamental concepts of the individualized, personalized approach to patient care which is proven to be safe and more effective;
WHEREAS, physicians and other health care providers working on the front lines, utilizing their knowledge of epidemiology, pathophysiology and pharmacology, are often first to identify new, potentially life saving treatments;
WHEREAS, physicians are increasingly being discouraged from engaging in open professional discourse and the exchange of ideas about new and emerging diseases, not only endangering the essence of the medical profession, but more importantly, more tragically, the lives of our patients;
WHEREAS, thousands of physicians are being prevented from providing treatment to their patients, as a result of barriers put up by pharmacies, hospitals, and public health agencies, rendering the vast majority of healthcare providers helpless to protect their patients in the face of disease. Physicians are now advising their patients to simply go home (allowing the virus to replicate) and return when their disease worsens, resulting in hundreds of thousands of unnecessary patient deaths, due to failure-to-treat;
WHEREAS, this is not medicine. This is not care. These policies may actually constitute crimes against humanity…
The vision I have for the Web is about anything being potentially connected with anything. It is a vision that provides us with new freedom, and allows us to grow faster than we ever when we were fettered by the hierarchical classification systems into which we bound ourselves.
Tim Berners-Lee’s vision has been sabotaged and hijacked by Big Tech. It’s time reinvent a new hypertext language riding the Net to restore his vision of freedom, privacy, creativity and equal opportunity for all.